ETV6 mutations in early immature human T cell leukemias
暂无分享,去创建一个
A. Ferrando | M. Rue | A. Ambesi-Impiombato | G. Della Gatta | P. Van Vlierberghe | V. Tosello | M. Hadler | Isaura Rigo | E. Paietta | J. Racevskis | J. Rowe | S. Luger | P. Wiernik | A. Pérez-García | J. E. Haydu
[1] F. Speleman,et al. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies , 2011, British journal of haematology.
[2] S. Shurtleff,et al. IDH1 and IDH2 mutations in pediatric acute leukemia , 2011, Leukemia.
[3] A. Ferrando,et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia , 2011, Nature Genetics.
[4] Andrew P. Stubbs,et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. , 2011, Cancer cell.
[5] J. Licht,et al. DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.
[6] A. Ferrando,et al. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. , 2011, Blood reviews.
[7] N. Friedman,et al. Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis , 2011, Cell.
[8] B. Levi,et al. Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress , 2010, Nature Cell Biology.
[9] C. Bach,et al. Leukemogenic transformation by HOXA cluster genes. , 2010, Blood.
[10] Christopher P Crum,et al. p63 in epithelial survival, germ cell surveillance, and neoplasia. , 2010, Annual review of pathology.
[11] Cheng Cheng,et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.
[12] M. König,et al. ETV6-NCOA2: A Novel Fusion Gene in Acute Leukemia Associated with Coexpression of T-Lymphoid and Myeloid Markers and Frequent NOTCH1 Mutations , 2008, Clinical Cancer Research.
[13] Govind Bhagat,et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia , 2007, Nature Medicine.
[14] A. Ferrando,et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia , 2007, The Journal of experimental medicine.
[15] J. Soulier,et al. Transforming potential of the T‐cell acute lymphoblastic leukemia‐associated homeobox genes HOXA13, TLX1, and TLX3 , 2006, Genes, chromosomes & cancer.
[16] Jill P. Mesirov,et al. Comparative gene marker selection suite , 2006, Bioinform..
[17] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[18] Xi C. He,et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.
[19] A. Bhandoola,et al. From stem cell to T cell: one route or many? , 2006, Nature Reviews Immunology.
[20] R. Stam,et al. Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias. , 2005, Blood.
[21] N. Copeland,et al. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. , 2005, Blood.
[22] P. Pandolfi,et al. The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63 , 2005, Oncogene.
[23] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[25] B. Löwenberg,et al. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia , 2005, Oncogene.
[26] S. Bohlander. ETV6: a versatile player in leukemogenesis. , 2005, Seminars in cancer biology.
[27] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[28] S. Orkin,et al. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. , 2004, Genes & development.
[29] R. Gentleman,et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. , 2004, Blood.
[30] M. Caligiuri,et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia , 2004, The Lancet.
[31] J. Mesirov,et al. Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data , 2003, Machine Learning.
[32] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[33] L. Matrisian,et al. TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1 , 2000, Molecular and Cellular Biology.
[34] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[35] A. Ferrando,et al. The role of NOTCH1 signaling in T-ALL. , 2009, Hematology. American Society of Hematology. Education Program.
[36] A. Jackson,et al. Luciferase reporter assay. , 2006, Sub-cellular biochemistry.